Health-related quality of life, visual function and treatment satisfaction following intravitreal dexamethasone implant for diabetic macular edema

References

• FrankRNDiabetic retinopathyN Engl J Med20043501485814702427
   PubMed Web of Science ®Google Scholar
• YauJWRogersSLKawasakiRGlobal prevalence and major risk factors of diabetic retinopathyDiabetes Care201235355656422301125
   PubMed Web of Science ®Google Scholar
• KleinRKleinBEMossSEDavisMDDeMetsDLThe Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edemaOphthalmology19849112146414746521986
   PubMed Web of Science ®Google Scholar
• [No authors listed]Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research GroupOphthalmology19919857667852062512
   PubMed Web of Science ®Google Scholar
• MitchellPBandelloFSchmidt-ErfurthUThe RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edemaOphthalmology2011184615625
   Web of Science ®Google Scholar
• HeierJSKorobelnikJFBrownDMIntravitreal aflibercept for diabetic macular edema: 148-week results from the VISTA and VIVID studiesOphthalmology2016123112376238527651226
   PubMed Web of Science ®Google Scholar
• GonzalezVHCampbellJHolekampNMEarly and long-term responses to anti-vascular endothelial growth factor therapy in diabetic macular edema: analysis of protocol I dataAm J Ophthalmol2016172727927644589
   PubMed Web of Science ®Google Scholar
• BresslerSBAyalaARBresslerNMPersistent macular thickening after ranibizumab treatment for diabetic macular edema with vision impairmentJAMA Ophthalmol2016134327828526746868
   PubMed Web of Science ®Google Scholar
• BeckRWEdwardsARAielloLPThree-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edemaArch Ophthalmol2009127324525119273785
   PubMedGoogle Scholar
• PacellaELa TorreGTurchettiPEvaluation of efficacy dexamethasone intravitreal implant compared to treatment with anti-VEGF in the treatment of diabetic macular edemaSenses Sci201414164168
   Google Scholar
• BoyerDSYoonYHBelfortRJrThree-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edemaOphthalmology2014121101904191424907062
   PubMed Web of Science ®Google Scholar
• CallananDGGuptaSBoyerDSDexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edemaOphthalmology201312091843185123706947
   PubMed Web of Science ®Google Scholar
• MathewRPearceEMunirajuRAbdel-HayASivaprasadSMonthly OCT monitoring of Ozurdex for macular oedema related to retinal vascular diseases: re-treatment strategy (OCTOME Report 1)Eye201428331832624384961
   PubMed Web of Science ®Google Scholar
• GilliesMCLimLLCampainAA randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX studyOphthalmology2014121122473248125155371
   PubMed Web of Science ®Google Scholar
• GoñiFJStalmansIDenisPElevated intraocular pressure after intravitreal steroid injection in diabetic macular edema: monitoring and managementOphthalmol Ther201651476127164896
   PubMedGoogle Scholar
• RamuJYangYMenonGA randomized clinical trial comparing fixed vs pro-re-nata dosing of Ozurdex in refractory diabetic macular oedema (OZDRY study)Eye201529121603161226493038
   PubMed Web of Science ®Google Scholar
• MangioneCMLeePPGutierrezPRDevelopment of the 25-item National Eye Institute Visual Function QuestionnaireArch Ophthalmol200111971050105811448327
   PubMed Web of Science ®Google Scholar
• MangioneCMLeePPPittsJGutierrezPBerrySHaysRDPsychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test InvestigatorsArch Ophthalmol199811611149615049823352
   PubMed Web of Science ®Google Scholar
• BroseLSBradleyCPsychometric development of the individualized Retinopathy-Dependent Quality of Life Questionnaire (RetDQoL)Value Health201013111912719695003
   PubMed Web of Science ®Google Scholar
• BroseLSBradleyCPsychometric development of the Retinopathy Treatment Satisfaction Questionnaire (RetTSQ)Psychol Health Med200914674075420183546
   PubMed Web of Science ®Google Scholar
• PacellaFRomanoMRTurchettiPAn eighteen-month follow-up study on the effects of Intravitreal Dexamethasone Implant in diabetic macular edema refractory to anti-VEGF therapyInt J Ophthalmol20169101427143227803859
   PubMed Web of Science ®Google Scholar
• PacellaFFerraresiAFTurchettiPIntravitreal injection of Ozurdex(®) implant in patients with persistent diabetic macular edema, with six-month follow-upOphthalmol Eye Dis20168111627147895
   PubMedGoogle Scholar
• PacellaEVestriARMuscellaRPreliminary results of an intravitreal dexamethasone implant (Ozurdex®) in patients with persistent diabetic macular edemaClin Ophthalmol201371423142823901252
   PubMedGoogle Scholar
• MalclèsADotCVoirinNReal-life study in diabetic macular edema treated with dexamethasone implant: The Reldex StudyRetina Epub2016728
   Google Scholar
• MilneAJohnsonJATennantMRudniskyCDrydenDMMeasuring Health-Related Quality of Life for Patients with Diabetic RetinopathyRockville, MDAgency for Healthcare Research and Quality (US)2012
   Google Scholar
• OkamotoYOkamotoFHiraokaTOshikaTVision-related quality of life and visual function following intravitreal bevacizumab injection for persistent diabetic macular edema after vitrectomyJpn J Ophthalmol201458436937424777841
   PubMed Web of Science ®Google Scholar
• SuñerIJKokameGTYuEWardJDolanCBresslerNMResponsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trialsInvest Ophthalmol Vis Sci20095083629363519255158
   PubMed Web of Science ®Google Scholar
• AlagözNAlagözCYılmazIImmediate intraocular pressure changes following intravitreal dexamethasone implantJ Ocul Pharmacol Ther2016321444926540554
   PubMed Web of Science ®Google Scholar
• PacellaFAgostinelliECarlesimoSCManagement of anterior chamber dislocation of a dexamethasone intravitreal implant: a case reportJ Med Case Rep201610128227733187
   PubMedGoogle Scholar